This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Canada's Competition Bureau closes two investigations into pharmaceutical patent litigation settlements

( May 20, 2022, 14:24 GMT | Official Statement) -- MLex Summary: Canada’s Competition Bureau announced that it has closed two recent investigations into potentially anticompetitive patent litigation settlement agreements involving pharmaceutical drugs. Evidence gathered during the investigations suggested that the agreements were not anticompetitive. Nonetheless, the bureau said that such agreements have the potential to result in significant anticompetitive and economic harm – hence the importance of proactive enforcement efforts.Statement follows in full:...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections